Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

E-ISSN： 1873-4316|15|5|475-485

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.5, 2014-05, pp. : 475-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5983-5988

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5973-5982

Bentham Science Publishers

Access to resources Recommend Favorite

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 55-72

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 2-11

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3982-3990

Bentham Science Publishers

Access to resources Recommend Favorite